Singular Genomics Announces 1-for-30 Reverse Stock Split

The reverse stock split is intended to enable the Company to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The reverse stock split was approved by the Company's stockholders at the Annual Meeting of Stockholders held on May 29, 2024, with the final ratio determined by the Company's Board of Directors. The Company's transfer agent, Continental Stock Transfer & Trust Company, will act as the exchange agent for the reverse stock split. Stockholders ...